Open AccessPB2057: REAL ‐WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
Author(s) -
Perolla A.,
Pulluqi P.,
Cili A.,
Calliku E.,
Caja T.,
Ivanaj A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851060.08910.17
Subject(s) - ruxolitinib , myelofibrosis , medicine , international prognostic scoring system , hematology , population , clinical trial , overall survival , survival analysis , myelodysplastic syndromes , bone marrow , environmental health